We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Pfizer, Cellectis Enter Cancer Immunotherapy Collaboration

News   Jun 20, 2014

 
Pfizer, Cellectis Enter Cancer Immunotherapy Collaboration
 
 
 

RELATED ARTICLES

Another Piece of Ebola Virus Puzzle

News

Researchers have discovered the interaction between an Ebola virus protein and a protein in human cells that may be an important key to unlocking the pathway of replication of the killer disease in human hosts.

READ MORE

Specific Obesity-related Risk Factors for Kidney Cancer

News

A new study confirms the long-suspected role of obesity as a risk factor for developing renal cell carcinoma (RCC), a type of kidney cancer, and identifies several specific obesity-related factors.

READ MORE

World’s First Genetically Enhanced Human Vascular Cells

News

Scientists have generated the world's first genetically enhanced human vascular cells by targeting a single longevity gene, FOXO3.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE